Ela Borenstein is Program Director in the Market Development team, where she is responsible for the development and launch of a new initiative for Canadian funds. She joined BDC Capital in 2007 spending 9 years as an investor in healthcare and life sciences companies bringing over 20 years of management, entrepreneurial and consulting experience in the biopharmaceutical and related industries.
Prior to joining BDC, she was Chief Operating Officer at a VC-backed biotech firm. She previously held the position of Vice President in clinical, regulatory affairs and product strategy for various public and private companies, as well as Senior Vice President of Scientific Affairs for Technilab Pharma during the company’s successful IPO. Her diversified professional background includes senior management responsibilities in drug and medical device development as well as key involvement in product acquisition and M&A activities.
Ela is a Kauffman Fellow Class 17, a society for leaders in venture capital, as well as an advisor and guest lecturer with several organisations and universities.
Ela holds a Bachelor of Science in Chemistry from the University of Western Ontario, a Master of Science in Pharmacology from the University of Toronto and an MBA in Bio-Industries from the Université du Québec à Montréal.
BDC Capital Team
Experienced. Knowledgeable. Capitalized. Connected.
At BDC Venture Capital, we are a team of dedicated, seasoned investment professionals, who bring our investee companies the benefit of decades of experience in the space. Each of our team members has been chosen for their in-depth knowledge and industry experience in sales, marketing, business development, production and R&D. It’s a team our investee companies and investment partners can trust and count on.
Contact our BDC Venture Capital team to learn more about investment opportunities for your company.